Sheares Healthcare Singapore, the healthcare platform of investment major Temasek, has reached the last stage of negotiation to raise its interest to 90% in Kolkata, India-based hospital chain Medica Synergie and offering an exit to the chief founder, several sources told Moneycontrol.

Sheares had bought a majority stake in Medica Synergie in December 2021 from private equity company Quadria Capital.

One of the sources told the news outlet: “Sheares is looking to shore up its current stake from around 75 percent to around 90 percent in the firm via a combination of primary and secondary issue of shares.”

Another source said that as part of the proposed deal, Sheares has held negotiations to acquire the minority stake held by Medica Synergie chairman and founder Dr Alok Roy and associated entities.

Medica Synergie offers treatment for cardiac, neurological and kidney care, among others.

Earlier this week, Temasek acquired an additional 41% interest in India-based Manipal Health through its portfolio company Sheares Healthcare Group.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Temasek is said to have paid nearly $2bn to acquire the additional stake.

Following the purchase, Temasek now holds 59% stake in the hospital, up from 18% prior to the acquisition.